193 related articles for article (PubMed ID: 37666495)
1. Porphyromonas gingivalis suppresses oral squamous cell carcinoma progression by inhibiting MUC1 expression and remodeling the tumor microenvironment.
Lan Z; Zou KL; Cui H; Zhao YY; Yu GT
Mol Oncol; 2024 May; 18(5):1174-1188. PubMed ID: 37666495
[TBL] [Abstract][Full Text] [Related]
2. Porphyromonas gingivalis promotes the progression of oral squamous cell carcinoma by stimulating the release of neutrophil extracellular traps in the tumor immune microenvironment.
Guo ZC; Jing SL; Jia XY; Elayah SA; Xie LY; Cui H; Tu JB; Na SJ
Inflamm Res; 2024 May; 73(5):693-705. PubMed ID: 38150024
[TBL] [Abstract][Full Text] [Related]
3. Porphyromonas gingivalis promotes the progression of oral squamous cell carcinoma by activating the neutrophil chemotaxis in the tumour microenvironment.
Guo ZC; Jing SL; Jumatai S; Gong ZC
Cancer Immunol Immunother; 2023 Jun; 72(6):1523-1539. PubMed ID: 36513851
[TBL] [Abstract][Full Text] [Related]
4. Prevotella intermedia boosts OSCC progression through ISG15 upregulation: a new target for intervention.
Qin Y; Li Z; Liu T; Ma J; Liu H; Zhou Y; Wang S; Zhang L; Peng Q; Ye P; Duan N; Wang W; Wang X
J Cancer Res Clin Oncol; 2024 Apr; 150(4):206. PubMed ID: 38644421
[TBL] [Abstract][Full Text] [Related]
5. Role of Porphyromonas gingivalis in oral squamous cell carcinoma development: A systematic review.
Lafuente Ibáñez de Mendoza I; Maritxalar Mendia X; García de la Fuente AM; Quindós Andrés G; Aguirre Urizar JM
J Periodontal Res; 2020 Jan; 55(1):13-22. PubMed ID: 31529626
[TBL] [Abstract][Full Text] [Related]
6.
Liu S; Zhou X; Peng X; Li M; Ren B; Cheng G; Cheng L
J Immunol; 2020 Jul; 205(1):282-289. PubMed ID: 32471882
[TBL] [Abstract][Full Text] [Related]
7.
Wen L; Mu W; Lu H; Wang X; Fang J; Jia Y; Li Q; Wang D; Wen S; Guo J; Dai W; Ren X; Cui J; Zeng G; Gao J; Wang Z; Cheng B
J Dent Res; 2020 Jun; 99(6):666-675. PubMed ID: 32298192
[TBL] [Abstract][Full Text] [Related]
8. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model.
Binder Gallimidi A; Fischman S; Revach B; Bulvik R; Maliutina A; Rubinstein AM; Nussbaum G; Elkin M
Oncotarget; 2015 Sep; 6(26):22613-23. PubMed ID: 26158901
[TBL] [Abstract][Full Text] [Related]
9. Porphyromonas gingivalis Activation of Tumor-Associated Macrophages via DOK3 Promotes Recurrence of Oral Squamous Cell Carcinoma.
Li CX; Su Y; Gong ZC; Liu H
Med Sci Monit; 2022 Oct; 28():e937126. PubMed ID: 36210538
[TBL] [Abstract][Full Text] [Related]
10. Porphyromonas gingivalis in oral squamous cell carcinoma: a review.
Singh S; Singh AK
Microbes Infect; 2022; 24(3):104925. PubMed ID: 34883247
[TBL] [Abstract][Full Text] [Related]
11. Porphyromonas gingivalis increases the invasiveness of oral cancer cells by upregulating IL-8 and MMPs.
Ha NH; Park DG; Woo BH; Kim DJ; Choi JI; Park BS; Kim YD; Lee JH; Park HR
Cytokine; 2016 Oct; 86():64-72. PubMed ID: 27468958
[TBL] [Abstract][Full Text] [Related]
12. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
13. Serum Levels of Interleukin-6 and Titers of Antibodies Against
Park DG; Woo BH; Lee BJ; Yoon S; Cho Y; Kim YD; Park HR; Song JM
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167516
[TBL] [Abstract][Full Text] [Related]
14. Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3.
He L; Guo J; Fan Z; Yang S; Zhang C; Cheng B; Xia J
Cell Signal; 2023 Jun; 106():110635. PubMed ID: 36813147
[TBL] [Abstract][Full Text] [Related]
15. The prevalence rate of periodontal pathogens and its association with oral squamous cell carcinoma.
Chang C; Geng F; Shi X; Li Y; Zhang X; Zhao X; Pan Y
Appl Microbiol Biotechnol; 2019 Feb; 103(3):1393-1404. PubMed ID: 30470868
[TBL] [Abstract][Full Text] [Related]
16. MUC1 gene silencing inhibits proliferation, invasion, and migration while promoting apoptosis of oral squamous cell carcinoma cells.
Zhang AM; Chi XH; Bo ZQ; Huang XF; Zhang J
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31439759
[TBL] [Abstract][Full Text] [Related]
17.
Chang C; Wang H; Liu J; Pan C; Zhang D; Li X; Pan Y
ACS Infect Dis; 2019 Aug; 5(8):1336-1347. PubMed ID: 31243990
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of Porphyromonas gingivalis-derived phosphoethanolamine dihydroceramide on acid ceramidase expression in oral squamous cells.
Yamada C; Ho A; Nusbaum A; Xu R; Davey ME; Nichols F; Mao C; Movila A
J Cell Mol Med; 2023 May; 27(9):1290-1295. PubMed ID: 37016912
[TBL] [Abstract][Full Text] [Related]
19. Role of Stromal Fibroblast-Induced WNT7A Associated with Cancer Cell Migration Through the AKT/CLDN1 Signaling Axis in Oral Squamous Cell Carcinoma.
Kayamori K; Katsube KI; Hirai H; Harada H; Ikeda T
Lab Invest; 2023 Oct; 103(10):100228. PubMed ID: 37541622
[TBL] [Abstract][Full Text] [Related]
20. sRNA23392 packaged by Porphyromonas gingivalis outer membrane vesicles promotes oral squamous cell carcinomas migration and invasion by targeting desmocollin-2.
Liu D; Liu S; Liu J; Miao L; Zhang S; Pan Y
Mol Oral Microbiol; 2021 Jun; 36(3):182-191. PubMed ID: 33764008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]